Cargando…
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis
BACKGROUND: Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies in order to enhance success rates, but the true benefit is actively debated. Growth hormone (GH) supplementation was assessed in poor-prognosis women undergoing fresh IVF transfer cycles. METHODS: Data we...
Autores principales: | Keane, Kevin N, Yovich, John L, Hamidi, Anahita, Hinchliffe, Peter M, Dhaliwal, Satvinder S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640074/ https://www.ncbi.nlm.nih.gov/pubmed/28993395 http://dx.doi.org/10.1136/bmjopen-2017-018107 |
Ejemplares similares
-
DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis
por: Keane, Kevin N., et al.
Publicado: (2018) -
Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosis
por: Keane, Kevin N, et al.
Publicado: (2019) -
The Concept of Growth Hormone Deficiency Affecting Clinical Prognosis in IVF
por: Yovich, John L., et al.
Publicado: (2019) -
The Evolving Concept of Poor-Prognosis for Women Undertaking IVF and the Notion of Growth Hormone as an Adjuvant; A Single-Center Viewpoint
por: Yovich, John L., et al.
Publicado: (2019) -
Importance of IGF-I levels in IVF: potential relevance for growth hormone (GH) supplementation
por: Gleicher, Norbert, et al.
Publicado: (2022)